Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2021
Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistencyStephen F Kry, Jessica Lye, Catharine H Clark, et al.Psycho-Oncology|February 9, 2025
Frailty and Sleep in Adult Survivors of Childhood Cancer: A Childhood Cancer Survivor Study ReportLauren C Daniel, Margaret M Lubas, Huiqi Wang, et al.Cancers|November 27, 2025
Late Morbidity and Mortality in Survivors of Childhood Ependymoma: A Report from the Childhood Cancer Survivor Study (CCSS)Katharine R Lange, Peter de Blank, Mengqi Xing, et al.Blood|December 3, 2021
Modifiable risk factors for neurocognitive and psychosocial problems after Hodgkin lymphomaAnnaLynn M Williams, Sedigheh Mirzaei Salehabadi, Mengqi Xing, et al.Pediatric Blood & Cancer|May 21, 2025
Treatment-Related Risk Factors for Diabetes Mellitus in Childhood Cancer Survivors-A Case-Cohort Study Within Adult Life After Childhood Cancer in Scandinavia (ALiCCS)Line Kenborg, Peter H Asdahl, Smita Bhatia, et al.Nature Cancer|March 1, 2024
Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor StudyPeter M K de Blank, Katharine R Lange, Mengqi Xing, et al.Clinical Orthopaedics and Related Research|May 18, 2022
What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study ReportErik J Geiger, Wei Liu, Deo Kumar Srivastava, et al.Journal of Visualized Experiments : Jove|May 1, 2018
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning SystemLaurence E Court, Kelly Kisling, Rachel McCarroll, et al.Cell Reports|December 21, 2017
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic AcidemiaDing An, Jessica L Schneller, Andrea Frassetto, et al.Plos Medicine|April 20, 2016
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialJake Dunning, Foday Sahr, Amanda Rojek, et al.Pageof 10